| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.12▲ | 7.08▲ | 7.12▲ | 37.14▼ | 47.00▼ |
| MA10 | 7.05▲ | 7.04▲ | 6.66▲ | 45.24▼ | 50.63▼ |
| MA20 | 7.02▲ | 6.64▲ | 23.04▼ | 50.84▼ | 48.62▼ |
| MA50 | 7.11▲ | 31.56▼ | 41.94▼ | 52.76▼ | 46.42▼ |
| MA100 | 6.67▲ | 42.73▼ | 47.63▼ | 48.70▼ | 47.41▼ |
| MA200 | 18.75▼ | 48.25▼ | 52.13▼ | 45.96▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.020▲ | 1.875▲ | -0.197▼ | -4.711▼ | -2.532▼ |
| RSI | 57.284▲ | 15.759▼ | 13.634▼ | 19.734▼ | 26.156▼ |
| STOCH | 87.012▲ | 73.871 | 72.565 | 48.100 | 59.502 |
| WILL %R | -11.475▲ | -21.695▲ | -21.192▲ | -97.887▼ | -97.887▼ |
| CCI | 115.586▲ | 53.082 | 89.554 | -232.030▼ | -425.636▼ |
|
Tuesday, September 30, 2025 11:04 AM
MoonLake Immunotherapeutics (NASDAQ:MLTX) faces revised projections as quarterly deficits impact sector trends. Clinical-stage healthcare developments influence Nasdaq Composite, Nasdaq Top 100, and ...
|
|
Tuesday, September 30, 2025 10:34 AM
MoonLake Immunotherapeutics (MLTX) stock gains even as analysts downgrade the company after a Phase 3 trial miss for its lead drug, sonelokimab. Read more here.
|
|
Tuesday, September 30, 2025 09:08 AM
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into MoonLake Immunotherapeutics (NASDAQ: MLTX) for potential violations of the federal securities laws. If you ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 6.41 | 7.47 | 6.08 | 7.15 | 35,694,711 |
| 29/09/25 | 6.975 | 7.14 | 5.95 | 6.245 | 79,682,418 |
| 26/09/25 | 56.81 | 62.75 | 56.68 | 61.99 | 1,149,831 |
| 25/09/25 | 53.95 | 57.01 | 53.43 | 56.38 | 751,495 |
| 24/09/25 | 52.20 | 54.615 | 52.00 | 53.945 | 469,540 |
| 23/09/25 | 54.70 | 55.125 | 52.30 | 52.54 | 719,059 |
| 22/09/25 | 53.60 | 55.525 | 52.6201 | 54.98 | 464,837 |
| 19/09/25 | 54.00 | 55.00 | 52.7163 | 53.78 | 649,464 |
| 18/09/25 | 51.37 | 54.635 | 51.185 | 54.16 | 725,473 |
| 17/09/25 | 53.76 | 54.51 | 50.84 | 51.18 | 1,372,154 |
|
|
||||
|
|
||||
|
|